ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir
Author(s): Mattes FM, Hainsworth EG, Hassan-Walker AF, Burroughs AK, Sweny P, Griffiths PD, Emery VC
Source: JOURNAL OF INFECTIOUS DISEASES    Volume: 191    Issue: 1    Pages: 89-92    Published: JAN 1 2005  
Times Cited: 34     References: 15     
Abstract: The availability of valganciclovir (VGCV) has significantly simplified the treatment of human cytomegalovirus (HCMV) infection after solid-organ transplantation. We show that there was no difference in the kinetics of the decrease in HCMV load after preemptive therapy with VGCV in 22 solid-organ transplant recipients (T-1/2 = 2.16 days), compared with that in 23 patients treated with intravenous ganciclovir (GCV) (T-1/2 = 1.73 days; P = .63). Preemptive therapy with VGCV pro vides control of HCMV replication that is comparable to that achieved with preemptive intravenous therapy with GCV.
Document Type: Article
Language: English
Reprint Address: Emery, VC (reprint author), UCL Royal Free & Univ Coll Med Sch, Div Infect & Immun, Ctr Virol, Rowland Hill St, London NW3 2QG, England
Addresses:
1. UCL Royal Free & Univ Coll Med Sch, Div Infect & Immun, Ctr Virol, London NW3 2QG, England
2. UCL Royal Free & Univ Coll Med Sch, Liver Transplant Unit, London, England
3. UCL Royal Free & Univ Coll Med Sch, Renal Transplant Unit, London, England
Publisher: UNIV CHICAGO PRESS, 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
Subject Category: Infectious Diseases
IDS Number: 877JF
ISSN: 0022-1899
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo